FFA
JAZZ icon

Frazier Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Frazier Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$379 Buy
+2
New +$350 ﹤0.01% 744

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Frazier Financial Advisors's JAZZ Position: Q1 2026 in Review

Frazier Financial Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 2 shares worth $379. The stake represents ﹤0.01% of the portfolio and ranks #744 among its holdings.

570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Frazier Financial Advisors held 2 shares of Jazz Pharmaceuticals worth $379 as of Q1 2026.
  • Jazz Pharmaceuticals was a new Frazier Financial Advisors position in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q1 2026, its #744 holding.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Frazier Financial Advisors's 13F filing for Q1 2026, filed 5 May 2026.